NORTH RUN CAPITAL, LP
NORTH RUN CAPITAL, LP is a Series C+ fund in the US investing in Healthcare, technology and industrials.
- Stages
- Series C+
- Sectors
- Healthcare, technology, industrials
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2002
- Assets under management
- $204.1M
- Website
- northruncapital.com
Check size not disclosed
Thesis
North Run Capital, LP, founded in 2002 and headquartered in Boston, Massachusetts, is an investment management firm focused on value investing and event-driven strategies in public markets, primarily within the United States. The firm employs a generalist mandate, utilizing bottom-up fundamental research to identify undervalued small- and mid-cap public equities. A key strategy involves Private Investment in Public Equity (PIPE) deals, where they provide growth capital for discounted equity stakes, often targeting companies undergoing restructurings, management changes, or facing regulatory catalysts. Their investment horizon is typically event-driven, with positions sized to influence outcomes or capitalize on specific catalysts. The firm deploys capital across sectors including technology, healthcare, and industrials, preferring to take meaningful, disclosed stakes to engage with management. While AUM reports vary significantly, recent filings suggest figures around $204.1 million. The firm manages capital through pooled investment vehicles, often in a master-feeder arrangement, and has transitioned to a leaner operating model focused on investment performance. They operate as an Exempt Reporting Adviser (ERA) and maintain a low profile.
Common questions
Does NORTH RUN CAPITAL, LP invest at the Series C+ stage?
Yes. NORTH RUN CAPITAL, LP lists Series C+ among the stages it invests in.
Where does NORTH RUN CAPITAL, LP invest?
NORTH RUN CAPITAL, LP invests in the US.